Session Details

Antipsychotic Drug Use

Tuesday, 10 February 2004 10:30 -12:30

Promenade Meeting Room 4

Co-Chair Kees C van Heeringen University HospitalBelgium
Co-Chair Thomas J Raedler University Hospital Hamburg-EppendorfGermany

Risperidone in the treatment of acute schizophrenia
  • Thomas J Raedler, University Hospital Hamburg-Eppendorf, Germany
  • Clinical evaluation of the short-term effect of orally disintegrating Olanzapine tablets on agitation and cooperation
  • Prof dr Kees C van Heeringen, University Hospital, Belgium
  • Atypical antipsychotics - Side effects profile
  • Daniel C Vasile, Central Military Hospital, Romania
  • Severe and fatal side effects due to drug- drug interactions
  • Gabriel Eckermann, Bezirkskrankenhaus Kaufbeuren, Germany
  • Antipsychotic drug effect and frontal activity: A prospective, longitudinal study in acutely ill manic patients using fMRI
  • Dieter F Braus, University of Hamburg, NeuroImage Nord (NN), Germany
  • Withdrawn: Serum creatine kinase activity during treatment with typical and atypical antipsychotic agents
  • Ilya Reznik, Beer-Yakov Regional Mental Health Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Israel
  • Diffusion-weighted MRI study of amygdala in patients with schizophrenia
  • Paolo Brambilla, University of Verona, Italy
  • Regional cerebral blood flow in first episode schizophrenia - SPECT assessment after atypical antipsychotics
  • Prof Mihai D Gheorghe, Central Military Hospital, Romania